Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LifeStance Health Group, Inc. - Common Stock (NQ:LFST)

5.440 -0.140 (-2.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about LifeStance Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Earnings Economy
LFST Q2 Deep Dive: Productivity Initiatives and Technology Investments Drive Margin Expansion
Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.6% year on year to $345.3 million. On the other hand, next quarter’s... 
Via StockStory
Why LifeStance Health Group (LFST) Stock Is Up Today
Shares of behavioral health company LifeStance Health (NASDAQ:LFST) jumped 11% in the afternoon session after the company reported mixed second-quarter 2025 results, delivering an earnings beat and a... 
Via StockStory
Topics Earnings Initial Public Offering Lawsuit
LifeStance Health Group’s (NASDAQ:LFST) Q2 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations
Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.6% year on year to $345.3 million. On the other hand, next quarter’s... 
Via StockStory
LifeStance Health Group Inc (NASDAQ:LFST) Reports Q2 2025 Revenue Growth and Narrowed Losses
LifeStance Health reports Q2 2025 revenue growth of 11% to $345.3M, narrowed losses, and strong cash flow. Shares remain muted despite improved profitability and raised EBITDA guidance. 
Via Chartmill
LifeStance (LFST) Q2 Revenue Jumps 11%
Via The Motley Fool
Earnings Scheduled For August 7, 2025
 
Via Benzinga
LifeStance Health Gr's Earnings Outlook
 
Via Benzinga
Earnings Scheduled For May 7, 2025
 
Via Benzinga
LifeStance Health Group (LFST) Reports Earnings Tomorrow: What To Expect
Behavioral health company LifeStance Health (NASDAQ:LFST) will be reporting earnings this Thursday before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
3 Stocks Under $10 with Warning Signs
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack... 
Via StockStory
Topics Supply Chain
3 Small-Cap Stocks We Find Risky
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Why LifeStance Health Group (LFST) Stock Is Trading Lower Today
Shares of behavioral health company LifeStance Health (NASDAQ:LFST) fell 3.4% in the afternoon session after the stock hit a new 52-week low of $4.60. The drop reflects ongoing investor concerns and... 
Via StockStory
Topics Artificial Intelligence Economy Government
1 Healthcare Stock with Competitive Advantages and 2 to Be Wary Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
1 Oversold Stock Ready to Bounce Back and 2 to Keep Off Your Radar
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
3 Cash-Producing Stocks with Open Questions
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
3 of Wall Street’s Favorite Stocks Facing Headwinds
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Economy
3 Unprofitable Stocks in Hot Water
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
LFST Q1 Earnings Call: Outpatient Behavioral Health Sees Stable Growth, Margin Improvement, and Shifts in Clinician Incentives
Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.8% year on year to $333 million. Its non-GAAP profit of $0.05 per share... 
Via StockStory
Light & Wonder, Rocket Lab, AMC Entertainment, LifeStance Health Group, and Xerox Stocks Trade Up, What You Need To Know
A number of stocks jumped in the morning session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting... 
Via StockStory
Topics Government Stocks World Trade
This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
Q1 Earnings Highlights: LifeStance Health Group (NASDAQ:LFST) Vs The Rest Of The Outpatient & Specialty Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at outpatient & specialty care stocks,... 
Via StockStory
Topics Artificial Intelligence
3 Stocks Under $10 Skating on Thin Ice
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
1 Growth Stock to Add to Your Roster and 2 to Approach with Caution
Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID... 
Via StockStory
3 High-Flying Stocks Skating on Thin Ice
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
Topics Artificial Intelligence
LifeStance Health Group’s (NASDAQ:LFST) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations
Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.8% year on year to $333 million. On the other hand, next quarter’s... 
Via StockStory
LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect
Behavioral health company LifeStance Health (NASDAQ:LFST) will be reporting earnings tomorrow before the bell. Here’s what you need to know. 
Via StockStory
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.